News
Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...
With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...
A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...
Click on the status to view our full coverage. Semaglutide (Novo Nordisk) Glucagon-like peptide-1 receptor agonist To improve walking distance in patients with type 2 diabetes and symptomatic ...
With prescription options like semaglutide (Ozempic ... GLP-1 alternatives - options that don't rely on needles, synthetic compounds, or monthly refills. This demand is driven by several common ...
Opko Health Inc. (OPK) reported a net loss for the first quarter of 2025, with earnings per share (EPS) missing analyst expectations. The company posted an EPS of -$0.10, compared to the ...
Opko Health Inc. (OPK) reported a net loss for the first quarter of 2025, with earnings per share (EPS) missing analyst expectations. The company posted an EPS of -$0.10, compared to the forecasted ...
Along with possible heart benefits, some animal studies suggest that certain compounds found in the reishi ... effects of reishi mushrooms. Dosage recommendations vary based on the form used ...
an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old and above. Tidepool, an open-source diabetes non-profit founded in 2013 and driving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results